The underestimated preventive effects of flexible sigmoidoscopy screening: re-analysis and meta-analysis of randomized trials

Gespeichert in:
Bibliographische Detailangaben
Titel: The underestimated preventive effects of flexible sigmoidoscopy screening: re-analysis and meta-analysis of randomized trials
Autoren: Hermann Brenner, Thomas Heisser, Rafael Cardoso, Michael Hoffmeister
Quelle: Eur J Epidemiol
Verlagsinformationen: Springer Science and Business Media LLC, 2024.
Publikationsjahr: 2024
Schlagwörter: Male, Female [MeSH], Aged [MeSH], Early Detection of Cancer/methods [MeSH], Colorectal Neoplasms/diagnosis [MeSH], Mass Screening/methods [MeSH], Humans [MeSH], Trials, Incidence [MeSH], Middle Aged [MeSH], Colorectal cancer, Risk, Flexible sigmoidoscopy, Colorectal Neoplasms/epidemiology [MeSH], Randomized Controlled Trials as Topic [MeSH], Male [MeSH], Incidence, Sigmoidoscopy [MeSH], Screening, Colorectal Neoplasms/prevention, Middle Aged, 03 medical and health sciences, 0302 clinical medicine, Humans, Mass Screening, Female, Colorectal Neoplasms, Sigmoidoscopy, Early Detection of Cancer, Aged, Randomized Controlled Trials as Topic
Beschreibung: Flexible sigmoidoscopy (FS), which is less invasive, resource intensive and costly than colonoscopy, is among the recommended screening options for colorectal cancer (CRC). Four large randomized trials consistently reported statistically significant, albeit modest effects of screening by FS on CRC incidence. However, their effect estimates included cancers that were already prevalent at recruitment and could not have been prevented by screening. We performed a re-analysis and meta-analysis of two of the trials (including the largest one) to estimate reduction of truly incident cases by a single FS offered between 55 and 64 years of age among the “at risk study population” without prevalent CRC at recruitment. In meta-analyses of data reported after more than 15 years of follow-up, relative risk (95% CI) in intention-to-screen and per-protocol analyses were 0.71 (0.66–0.76) and 0.59 (0.55–0.65) for any CRC, and 0.52 (0.47–0.57) and 0.34 (0.30–0.39) for distal CRC, respectively. These results indicate much stronger effects than those suggested by the original reports and imply that a single screening FS can prevent approximately two out of three distal incident CRC cases within 15 + years of follow-up.
Publikationsart: Article
Other literature type
Sprache: English
ISSN: 1573-7284
0393-2990
DOI: 10.1007/s10654-024-01120-w
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38642235
https://repository.publisso.de/resource/frl:6496271
Rights: CC BY
Dokumentencode: edsair.doi.dedup.....75405783c22f5d3c450ab30a52d26ca6
Datenbank: OpenAIRE
Beschreibung
Abstract:Flexible sigmoidoscopy (FS), which is less invasive, resource intensive and costly than colonoscopy, is among the recommended screening options for colorectal cancer (CRC). Four large randomized trials consistently reported statistically significant, albeit modest effects of screening by FS on CRC incidence. However, their effect estimates included cancers that were already prevalent at recruitment and could not have been prevented by screening. We performed a re-analysis and meta-analysis of two of the trials (including the largest one) to estimate reduction of truly incident cases by a single FS offered between 55 and 64 years of age among the “at risk study population” without prevalent CRC at recruitment. In meta-analyses of data reported after more than 15 years of follow-up, relative risk (95% CI) in intention-to-screen and per-protocol analyses were 0.71 (0.66–0.76) and 0.59 (0.55–0.65) for any CRC, and 0.52 (0.47–0.57) and 0.34 (0.30–0.39) for distal CRC, respectively. These results indicate much stronger effects than those suggested by the original reports and imply that a single screening FS can prevent approximately two out of three distal incident CRC cases within 15 + years of follow-up.
ISSN:15737284
03932990
DOI:10.1007/s10654-024-01120-w